Amedisys Completes $22.8 Million Private Placement Financing Funding to Support Amedisys' Growth Strategy BATON ROUGE, La., Dec. 1 /PRNewswire-FirstCall/ -- Amedisys, Inc. (Nasdaq: "AMED" or the "Company"), one of America's leading home health nursing companies, today announced that it has completed a $22.8 million private placement financing. Pursuant to the terms of the purchase agreements, the Company sold 1.9 million shares of its common stock at a negotiated price of $12.00 per share. Amedisys will utilize approximately $4.4 million of the net proceeds from the financing to pay down debt. The remaining funds will be used for general corporate purposes and potential acquisitions. "The success of this financing reflects the confidence that investors maintain in Amedisys' ability to continue to create shareholder value," said William F. Borne, Chief Executive Officer. "We intend to continue our focus on internal growth through further development of our specialty clinical programs, and further our expansion through selected acquisitions." "The Company is pleased to reaffirm previously stated earnings guidance for the year ended December 31, 2003 of $0.72 to $0.75 cents per diluted share." "We will generally focus our acquisition activity on organizations generating between $2 million and $20 million a year in revenue in our current geographic area of activity. We are in preliminary discussions with several organizations that meet these criteria," concluded Mr. Borne. Jefferies & Company Inc. and Raymond James & Associates acted as placement agents for the transaction. The shares of common stock have not been registered under the Securities Act of 1933, as amended, or state securities laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission (SEC) or an applicable exemption from the registration requirements. Amedisys has agreed to file a registration statement with respect to the shares within 10 days following the closing. This news release is not an offer to sell or the solicitation of an offer to buy the securities discussed herein. Amedisys, Inc., a leading provider of home health nursing services, is headquartered in Baton Rouge, Louisiana. The Company had approximately $129 million in revenue in 2002. Its common stock trades on the Nasdaq Stock Market under the symbol "AMED". This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products and services in the marketplace, competitive factors, changes in government reimbursement procedures, dependence upon third-party vendors, and other risks discussed in the Company's periodic filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. Additional information on this Company can be found on the World Wide Web http://www.amedisys.com/ Amedisys, Inc. EURO RSCG Life NRP Chief Financial Officer Investors/Media Greg Browne Brian Ritchie 225.292.2031 212.845.4269 DATASOURCE: Amedisys, Inc. CONTACT: Greg Browne, Chief Financial Officer of Amedisys, Inc., +1-225-292-2031, ; or Investors-Media, Brian Ritchie of EURO RSCG Life NRP, +1-212-845-4269, , for Amedisys, Inc. Web site: http://www.amedisys.com/

Copyright